Logos Global Management LP Bellus Health Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $7.16 Million - $9.6 Million	800,000 New	800,000 $8.45 Million
Q3 2020 Nov 16, 2020	SELL	$2.14 - $12.02 $1.28 Million - $7.21 Million	-600,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.88 - $11.15 $1.56 Million - $1.96 Million	-175,377 Reduced 22.62%	600,000 $6.17 Million
Q1 2020 May 15, 2020	BUY	$5.77 - $10.85 $2.02 Million - $3.81 Million	350,759 Added 82.61%	775,377 $7.74 Million
Q4 2019 Feb 14, 2020	BUY	$5.76 - $7.6 $2.45 Million - $3.23 Million	424,618 New	424,618 $3.23 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.